Myocardial infarction after COVID-19 vaccination-casual or causal?
Reads0
Chats0
About:
This article is published in Diabetes and Metabolic Syndrome: Clinical Research and Reviews.The article was published on 2021-04-14 and is currently open access. It has received 31 citations till now.read more
Citations
More filters
Journal ArticleDOI
Current evidence of COVID-19 vaccination-related cardiovascular events
Sajad Khiali,Afra Rezagholizadeh,Hosseini Fard Behzad,Hossein Bannazadeh Baghi,Taher Entezari-Maleki +4 more
TL;DR: In this paper , a comprehensive review aimed to provide an update on the etiology, pathophysiology, clinical features, and management of the cardiovascular adverse events associated with COVID-19 vaccines, including myocarditis, pericarditis, thrombosis with thrombinia syndrome, myocardial infarction, cardiac arrhythmias, hypertension, and stress-induced cardiomyopathy.
Journal ArticleDOI
Acute Myocardial Infarction After COVID-19 Vaccination: A Case Report
TL;DR: It is highlighted that the complication can occur during the mass vaccination programs and hence adequate precautionary measures like basic life support, EKG monitoring, and emergency ambulance services should be present in all primary and community health centers (PHC and CHC) to help in avoiding the COVID vaccination hesitancy among the general public.
Posted ContentDOI
Comparisons of the rate of acute myocardial infarction between COVID-19 patients and individuals received COVID-19 vaccines: a population-based study
Marasco, Domenico,楚楚 赵 +1 more
TL;DR: In this article , the authors compared the rates of acute myocardial infarction after COVID-19 infection and among the COVID19 vaccinated populations in Hong Kong, and they found that the vaccinated population had a higher rate of AMI than the unvaccinated population.
Journal ArticleDOI
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
TL;DR: A review of the safety and efficacy of SARS-CoV-2 vaccines can be found in this article, showing that the advantages of these vaccines for ending the pandemic and/or decreasing the mortality rate outweigh any risk for the rare cardiovascular complications.
Journal ArticleDOI
Biochemical Study for The Effect of Pfizer‐BioNTech COVID‐19 Vaccine
TL;DR: In pre-clinical development, these vaccines involve viral vectors as discussed by the authors , which are used in preclinical development of vaccines involving viral vectors, such as MMR, MMR, and MMR vaccine.
References
More filters
Journal ArticleDOI
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.
TL;DR: Denmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots and one death.
Journal ArticleDOI
Kounis syndrome: a new twist on an old disease
Nicholas G. Kounis,Andreas Mazarakis,Grigorios Tsigkas,Sotiris Giannopoulos,John A. Goudevenos +4 more
TL;DR: Kounis syndrome has revealed that the same mediators released from the same inflammatory cells are present in acute coronary events of nonallergic etiology, and drugs, substances targeting the stem cell factor that is essential for mast cell development, proliferation, survival, adhesion and homing could emerge as novel therapeutic ways capable to prevent acute coronary and acute cerebrovascular events.
Journal ArticleDOI
Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine.
TL;DR: This is the first reported case of DVT presenting as an adverse event post-SARS-CoV-2 vaccination, and the intense immunological response evoked by the second dose of vaccine could be a trigger for the thrombotic event described.
Journal ArticleDOI
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
Nicholas G. Kounis,Ioanna Koniari,Cesare de Gregorio,Dimitris Velissaris,Konstantinos Petalas,Aikaterini Brinia,Stelios F Assimakopoulos,Christos Gogos,Sophia N. Kouni,George N. Kounis,Gianfranco Calogiuri,Ming Yow Hung +11 more
TL;DR: A review of the current state of knowledge of immediate and delayed allergic reactions in the currently available vaccines against COVID-19, together with the general and specific therapeutic considerations is presented in this paper.
Posted ContentDOI
A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination
Andreas Greinacher,Thomas Thiele,Theodore E. Warkentin,Karin Weisser,Paul A. Kyrle,S. Eichinger +5 more
TL;DR: The AZD1222 vaccine is associated with development of a prothrombotic disorder that clinically resembles heparin-induced thrombocytopenia but which shows a different serological profile.